iSAM Funds UK Ltd Decreases Stock Holdings in Danaher Co. (NYSE:DHR)

iSAM Funds UK Ltd lowered its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 66.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,866 shares of the conglomerate's stock after selling 3,702 shares during the period. iSAM Funds UK Ltd's holdings in Danaher were worth $428,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in DHR. Norges Bank purchased a new stake in Danaher during the fourth quarter valued at about $2,130,740,000. Raymond James Financial Inc. bought a new stake in shares of Danaher in the fourth quarter worth about $391,172,000. Two Sigma Advisers LP grew its stake in shares of Danaher by 4,248.8% in the fourth quarter. Two Sigma Advisers LP now owns 1,639,500 shares of the conglomerate's stock worth $376,347,000 after purchasing an additional 1,601,800 shares during the last quarter. Capital World Investors grew its stake in shares of Danaher by 32.7% in the fourth quarter. Capital World Investors now owns 6,361,183 shares of the conglomerate's stock worth $1,460,215,000 after purchasing an additional 1,566,658 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its holdings in Danaher by 460.6% in the fourth quarter. Point72 Asset Management L.P. now owns 1,348,544 shares of the conglomerate's stock worth $309,558,000 after buying an additional 1,107,998 shares during the period. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insiders Place Their Bets

In related news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the transaction, the executive vice president now directly owns 15,179 shares of the company's stock, valued at $3,005,442. This trade represents a 51.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman Steven M. Rales sold 1,250,000 shares of the firm's stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the transaction, the chairman now directly owns 3,105,808 shares in the company, valued at $611,036,665.92. The trade was a 28.70% decrease in their ownership of the stock. The disclosure for this sale can be found here. 11.10% of the stock is owned by company insiders.

Danaher Price Performance

Shares of DHR stock traded down $2.69 on Friday, reaching $184.79. 2,814,188 shares of the company were exchanged, compared to its average volume of 3,469,794. The company has a market cap of $132.25 billion, a price-to-earnings ratio of 35.00, a P/E/G ratio of 2.66 and a beta of 0.80. The business has a 50-day moving average price of $195.01 and a 200 day moving average price of $215.71. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a net margin of 16.33% and a return on equity of 10.82%. The company had revenue of $5.74 billion during the quarter, compared to analysts' expectations of $5.58 billion. Equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be issued a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.69%. Danaher's dividend payout ratio is currently 24.85%.

Wall Street Analysts Forecast Growth

Several brokerages have commented on DHR. Citigroup restated a "buy" rating on shares of Danaher in a report on Monday, April 7th. HSBC decreased their price objective on shares of Danaher from $270.00 to $240.00 in a report on Friday, April 25th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research report on Monday, February 3rd. JPMorgan Chase & Co. dropped their target price on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating for the company in a report on Tuesday, April 22nd. Finally, Robert W. Baird dropped their target price on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $263.24.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.